EI
RCEL icon

EAM Investors’s Avita Medical RCEL Stock Holding History

EAM Investors’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-249,192
Closed -$3.64M – 354
2023
Q3 		$3.64M Buy
249,192
+75,436
+43% +$1.28M 0.7% 15
2023
Q2 		$2.96M Sell
173,756
-81,268
-32% -$1.19M 0.55% 53
2023
Q1 		$3.56M Buy
+255,024
New +$2.71M 0.7% 18

Other funds holding RCEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

EAM Investors's RCEL Position: Q4 2023 in Review

EAM Investors sold out of Avita Medical (RCEL) in Q4 2023, closing a stake of 249,192 shares — an estimated $3.64M sold.

EAM Investors first reported a position in RCEL in Q1 2023 and held it in 3 quarters. The position peaked at $3.64M in Q3 2023. 84 funds tracked by Wall St. Rank hold RCEL as of Q4 2023.

  • EAM Investors reported no remaining Avita Medical position as of Q4 2023 after selling out during the quarter.
  • EAM Investors sold 249,192 Avita Medical shares in Q4 2023, an estimated $3.64M.
  • EAM Investors first reported a position in Avita Medical in Q1 2023 and held it in 3 quarters.
  • EAM Investors's Avita Medical position peaked at $3.64M in Q3 2023.
  • 84 funds tracked by Wall St. Rank held Avita Medical as of Q4 2023.

Based on EAM Investors's 13F filing for Q4 2023, filed 14 Feb 2024.